The US Therapeutic Hypothermia Systems Market was valued at $59.5 Million in 2023 and projected to reach to $81.1 Million by 2028, representing a compound annual growth rate of 6.4%. The US therapeutic hypothermia systems market is positioned for sustained growth through 2028, driven by rising adoption in critical care settings and expanding clinical applications.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US therapeutic hypothermia systems market reached $59.5 million in 2023, demonstrating strong demand for temperature management solutions across American healthcare facilities.
With a CAGR of 6.4% through 2028, the US market is expanding faster than the global average of 6.3%, indicating accelerating adoption within the country's healthcare ecosystem.
The US benefits from sophisticated healthcare infrastructure and high penetration of critical care units, driving widespread implementation of therapeutic hypothermia technologies in hospitals and ICUs.
Increasing recognition among US clinicians of hypothermia's neuroprotective benefits for cardiac arrest and traumatic brain injury patients is fueling market expansion and technology adoption.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | CARDIOLOGY (Application) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 6.3% from 2023 to 2028 |
| Largest Segment | COOLING DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 0.29 (2023) |
| Revenue Forecast (Billions) | ~USD 0.4 (2028) |
| Segments Covered | Product, Application, Volume |
3 segment dimensions are covered across the global market.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CARDIOLOGY | 38.2 | 40.9 | 43.3 | 46 | 48.9 | 52.1 | 55.6 | 59.3 | 6.5 |
| NEONATAL CARE | 6.7 | 7.1 | 7.5 | 8 | 8.4 | 8.9 | 9.5 | 10.1 | 6.1 |
| NEUROLOGY | 42.9 | 45.8 | 48.6 | 51.4 | 54.5 | 57.9 | 61.7 | 65.5 | 6.2 |
| OTHER APPLICATIONS | 5.1 | 5.4 | 5.6 | 5.9 | 6.2 | 6.6 | 6.9 | 7.3 | 5.4 |
| TOTAL | 92.9 | 99.2 | 105 | 111.3 | 118 | 125.5 | 133.7 | 142.2 | 6.3 |
The US therapeutic hypothermia systems market was valued at $59.5 million in 2023 and is expected to reach $81.1 million by 2028.
The US market is growing at a compound annual growth rate (CAGR) of 6.4% from 2023 to 2028.
The US market is primarily driven by post-cardiac arrest care, acute ischemic stroke management, and traumatic brain injury treatment in hospital ICUs and specialized care centers.
Key growth factors in the US include rising cardiac arrest incidence, expanding ICU infrastructure, strong clinical guideline adoption, favorable reimbursement policies, and increasing awareness of neuroprotective benefits.
The US market utilizes both intravascular cooling systems and surface cooling technologies, with growing demand for portable, user-friendly devices that integrate with existing hospital workflows.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the therapeutic hypothermia systems market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.
The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as pharmaceutical & biotechnology industries, food & nutraceutical industries, and research laboratories) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:

Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
All major product manufacturers offering various therapeutic hypothermia systems were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value therapeutic hypothermia systems market was also split into various segments and subsegments at the region and country level based on:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Therapeutic hypothermia systems industry.
Therapeutic hypothermia, also known as targeted temperature management or induced hypothermia, is a medical treatment that involves lowering a patient’s body temperature for a specific period to provide therapeutic benefits. This intervention is often employed in certain medical conditions to reduce the risk of injury to tissues, particularly the brain, and improve overall outcomes. The primary goal of therapeutic hypothermia is to protect the body’s organs, especially the brain, from damage following events such as cardiac arrest, traumatic brain injury, stroke, or neonatal hypoxic-ischemic encephalopathy (a type of brain injury that occurs when there is a lack of oxygen and blood flow to the brain in newborns).
MarketsandMarkets offers the following customizations for this market report:
Full forecast, segment splits, and company analysis for all Therapeutic Hypothermia Systems Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report